Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy
- PMID: 25796054
- DOI: 10.1093/eurheartj/ehv082
Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy
Comment on
-
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.Eur Heart J. 2015 May 21;36(20):1242-51. doi: 10.1093/eurheartj/ehv038. Epub 2015 Feb 25. Eur Heart J. 2015. PMID: 25718355 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical